Advertisement

Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma

  • Masao Omata
  • Kiwamu Okita
Conference proceedings

Table of contents

  1. Front Matter
    Pages I-XI
    PDF

  2. Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma

    1. Front Matter
      Pages 1-1
      PDF
    2. Opening Lecture: What is Accomplished and What is Needed
      Masao Omata
      Pages 3-21

  3. Lamivudine Therapy for Hepatitis B

    1. Front Matter
      Pages 23-23
      PDF
    2. New Anti-Virals Against Wild-Type and Lamivudine-Resistant Hepatitis B Virus
      Naoya Kato, Suzane Kioko Ono-Nita, Masao Omata
      Pages 25-31
    3. Lamivudine Therapy of Hepatitis B in Japan
      Michio Sata
      Pages 32-37
    4. Early Detection of Lamivudine Resistant Mutant in Chronic Hepatitis B Patients Using a Novel Sensitive Method
      Takeshi Okanoue, Kohjiro Mori, Toshihiko Kirishima, Masahito Minami
      Pages 38-44

  4. New Anti-Virals: HBV

    1. Front Matter
      Pages 45-45
      PDF
    2. New Antiviral Treatment for Chronic Hepatitis B
      Man-Fung Yuen, Ching-Lung Lai
      Pages 47-56
    3. New Antiviral Therapy: Adefovir Dipivoxil for HBV
      Marion Peters
      Pages 57-62
    4. Development of Entecavir: Superior Therapy for the Management of Chronic Hepatitis B Viral Infection
      Deborah DeHertogh, Richard Colonno, William Fiske, Anne Cross
      Pages 63-73

  5. Therapy for Hepatitis B and Prevention of HCC

    1. Front Matter
      Pages 75-75
      PDF
    2. Therapy of Hepatitis B and Prevention of Hepatocellular Carcinoma
      Nancy Leung
      Pages 77-83
    3. Differences of Clinical Characteristics Among Japanese Patients with Hepatitis B Virus Genotypes B and C
      Masashi Mizokami, Etsuro Orito
      Pages 84-93

  6. HCV Replicon System

    1. Front Matter
      Pages 95-95
      PDF
    2. Establishment of a New Hepatitis C Virus-1 b Replicon
      Nobuyuki Enomoto, Naoya Sakamoto, Masayuki Kurosaki, Shinya Maekawa, Yoko Tanabe, Tsuyoshi Yamashiro et al.
      Pages 97-107
    3. Hepatitis C Virus Replication in Cell Culture
      Michael Frese, Volker Lohmann, Thomas Pietschmann, Artur Kaul, Nicole Krieger, Jens Bukh et al.
      Pages 108-122
    4. Characterization of the Interferon Alpha Response Against HCV in Hepatoma Cells
      Christoph Seeger, Qing Zhu, Ju-Tao Guo
      Pages 123-130

  7. New Anti-Virals: HCV

    1. Front Matter
      Pages 131-131
      PDF
    2. Hepatitis C: Development of a Ribavirin Liver-Targeting Prodrug
      Johnson Y. N. Lau
      Pages 133-139
    3. HCV Replicon Inhibitors: Mode of Action and Resistance Mapping
      Robert T. Sarisky
      Pages 140-154

  8. Interferon Therapy for Hepatitis C

    1. Front Matter
      Pages 155-155
      PDF
    2. Interferon Treatment Not Only Reduces the Risk of Hepatocellular Carcinoma But Also Improves Mortality in Patients with Chronic Hepatitis C Showing Biochemical Response, Especially in Patients with Advanced Liver Fibrosis
      Akinori Kasahara, Norio Hayashi
      Pages 157-166
    3. Favorable Outcome of Patients with C-Viral Liver Disease Treated with Interferon
      Osamu Yokosuka, Fumio Imazeki, Shigenobu Kawai, Kenichi Fukai
      Pages 167-175
    4. IFN Receptor and IFN Signals
      Hiroshi Yatsuhashi
      Pages 176-185

  9. Therapy for Hepatitis C and Prevention of HCC

    1. Front Matter
      Pages 187-187
      PDF
    2. Management and Treatment of Hepatitis C
      Leonard B. Seeff
      Pages 189-198
    3. Hepatitis C Virus and Hepatocellular Carcinoma
      Myron J. Tong
      Pages 199-208
    4. Randomized Trial of Post-Operative Interferon Therapy After Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma and Long-Term Outcome
      Shuhei Nishiguchi, Shoji Kubo
      Pages 209-218
    5. Roles of Antiviral Therapy in Chronic Hepatitis C Patients Should be Different According to the Stages of Liver Disease Progression
      Yasushi Shiratori
      Pages 219-228
    6. Significance of Sustained Inflammation in the Development of HCC from HCV-Associated Cirrhotic Patients and the Prevention of HCC by Anti-Inflammatory Agents
      Kazuo Tarao
      Pages 229-237

  10. Chemoprevention and Therapy for HCC

    1. Front Matter
      Pages 239-239
      PDF
    2. Chemoprevention of Hepatocellular Carcinoma with Retinoid
      Hisataka Moriwaki
      Pages 241-248
    3. Vitamin K2 Administration Improves the Prognoses of Patients with Hepatocellular Carcinoma Presenting High Levels of Serum Des-γ-Carboxy Prothrombin
      Yukihiro Koike, Yasushi Shiratori, Haruhiko Yoshida, Masao Omata
      Pages 249-250
    4. Combination Chemotherapy for Advanced Hepatocellular Carcinoma
      Shuichi Kaneko
      Pages 251-257
    5. Combined Intra-Arterial 5-Fluorouracil and Subcutaneous Interferon-Alpha Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombi in the Major Portal Branches
      Morito Monden, Masato Sakon, Hiroaki Nagano
      Pages 258-269

  11. Transplantation for HBV and HCV

    1. Front Matter
      Pages 271-271
      PDF
    2. Liver Transplantation for Hepatitis B Virus-Related Liver Disease
      Steven B. Porter, K. Rajender Reddy
      Pages 273-282
    3. Living Donor Liver Transplantation for Hepatitis B and C Cirrhosis
      Yasuhiko Sugawara, Masatoshi Makuuchi
      Pages 283-292
    4. Living Donor Liver Transplantation for HBV-/HCV-Related Diseases
      Tetsuya Kiuchi, Koichi Tanaka
      Pages 293-295

About these proceedings

Keywords

Carcinom Hepatitis B Hepatitis C Hepatocellular carcinoma infection viral infection virus

Editors and affiliations

  • Masao Omata
    • 1
  • Kiwamu Okita
    • 2
  1. 1.Department of Gastroenterology Graduate School of MedicineThe University of TokyoTokyoJapan
  2. 2.Department of Gastroenterology and HepatologyYamaguchi University School of MedicineYamaguchiJapan

Bibliographic information